174 related articles for article (PubMed ID: 15652520)
1. Plasminogen activator inhibitor-1 (PAI-1) stimulates human corneal epithelial cell adhesion and migration in vitro.
Wang Z; Sosne G; Kurpakus-Wheater M
Exp Eye Res; 2005 Jan; 80(1):1-8. PubMed ID: 15652520
[TBL] [Abstract][Full Text] [Related]
2. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix.
Ngamkitidechakul C; Burke JM; O'Brien WJ; Twining SS
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3135-41. PubMed ID: 11726614
[TBL] [Abstract][Full Text] [Related]
3. The role of laminin-5 in TGF alpha/EGF-mediated corneal epithelial cell motility.
Qin P; Kurpakus MA
Exp Eye Res; 1998 May; 66(5):569-79. PubMed ID: 9628804
[TBL] [Abstract][Full Text] [Related]
4. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
Whitley BR; Church FC
Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
[TBL] [Abstract][Full Text] [Related]
5. Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor.
Chandrasekher G; Ma X; Lallier TE; Bazan HE
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1422-8. PubMed ID: 11980856
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species (ROS) are essential mediators in epidermal growth factor (EGF)-stimulated corneal epithelial cell proliferation, adhesion, migration, and wound healing.
Huo Y; Qiu WY; Pan Q; Yao YF; Xing K; Lou MF
Exp Eye Res; 2009 Dec; 89(6):876-86. PubMed ID: 19635476
[TBL] [Abstract][Full Text] [Related]
7. The functions of exogenous and endogenous laminin-5 on corneal epithelial cells.
Ebihara N; Mizushima H; Miyazaki K; Watanabe Y; Ikawa S; Nakayasu K; Kanai A
Exp Eye Res; 2000 Jul; 71(1):69-79. PubMed ID: 10880277
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor type 2 in human corneal epithelium.
Williams DL; Risse B; Kim S; Saunders D; Orlin S; Baker MS; Jensen PJ; Lavker RM
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1669-75. PubMed ID: 10393034
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Sep; 36(8):488-94. PubMed ID: 17686008
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type 2 (PAI-2) is present in normal human conjunctiva.
Massaro-Giordano M; Marshall CM; Lavker RM; Jensen PJ; Risse Marsh BC
J Cell Physiol; 2005 Nov; 205(2):295-301. PubMed ID: 15887231
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator regulates cranial neural crest cell migration in vitro.
Agrawal M; Brauer PR
Dev Dyn; 1996 Nov; 207(3):281-90. PubMed ID: 8922527
[TBL] [Abstract][Full Text] [Related]
12. Chemotactic and haptotactic activities of fibronectin for cultured rabbit corneal epithelial cells.
Watanabe K; Nakagawa S; Nishida T
Invest Ophthalmol Vis Sci; 1988 Apr; 29(4):572-7. PubMed ID: 3356514
[TBL] [Abstract][Full Text] [Related]
13. Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration.
Morimoto K; Mishima H; Nishida T; Otori T
Thromb Haemost; 1993 Apr; 69(4):387-91. PubMed ID: 8497852
[TBL] [Abstract][Full Text] [Related]
14. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
15. Type IV collagen and corneal epithelial adhesion and migration. Effects of type IV collagen fragments and synthetic peptides on rabbit corneal epithelial cell adhesion and migration in vitro.
Cameron JD; Skubitz AP; Furcht LT
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2766-73. PubMed ID: 1894474
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of corneal epithelial migration by a synthetic peptide (PHSRN) corresponding to the second cell-binding site of fibronectin.
Kimura K; Hattori A; Usui Y; Kitazawa K; Naganuma M; Kawamoto K; Teranishi S; Nomizu M; Nishida T
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1110-8. PubMed ID: 17325153
[TBL] [Abstract][Full Text] [Related]
17. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy.
Naruse K; Lash GE; Bulmer JN; Innes BA; Otun HA; Searle RF; Robson SC
Placenta; 2009 May; 30(5):398-404. PubMed ID: 19272641
[TBL] [Abstract][Full Text] [Related]
18. Promotion of corneal epithelial wound healing in vitro and in vivo by annexin A5.
Watanabe M; Kondo S; Mizuno K; Yano W; Nakao H; Hattori Y; Kimura K; Nishida T
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1862-8. PubMed ID: 16638992
[TBL] [Abstract][Full Text] [Related]
19. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
20. Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing.
Maquerlot F; Galiacy S; Malo M; Guignabert C; Lawrence DA; d'Ortho MP; Barlovatz-Meimon G
Am J Pathol; 2006 Nov; 169(5):1624-32. PubMed ID: 17071586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
